128 related articles for article (PubMed ID: 24260246)
1. Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice.
Pascal LE; Ai J; Masoodi KZ; Wang Y; Wang D; Eisermann K; Rigatti LH; O'Malley KJ; Ma HM; Wang X; Dar JA; Parwani AV; Simons BW; Ittman MM; Li L; Davies BJ; Wang Z
PLoS One; 2013; 8(11):e79542. PubMed ID: 24260246
[TBL] [Abstract][Full Text] [Related]
2. Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.
Pascal LE; Su F; Wang D; Ai J; Song Q; Wang Y; O'Malley KJ; Cross B; Rigatti LH; Green A; Dhir R; Wang Z
Neoplasia; 2019 Aug; 21(8):752-764. PubMed ID: 31229879
[TBL] [Abstract][Full Text] [Related]
3. EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate.
Pascal LE; Ai J; Rigatti LH; Lipton AK; Xiao W; Gnarra JR; Wang Z
Angiogenesis; 2011 Sep; 14(3):331-43. PubMed ID: 21638067
[TBL] [Abstract][Full Text] [Related]
4. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
Ai J; Pascal LE; O'Malley KJ; Dar JA; Isharwal S; Qiao Z; Ren B; Rigatti LH; Dhir R; Xiao W; Nelson JB; Wang Z
Oncogene; 2014 May; 33(18):2286-94. PubMed ID: 23708662
[TBL] [Abstract][Full Text] [Related]
5. U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
Xiao W; Zhang Q; Habermacher G; Yang X; Zhang AY; Cai X; Hahn J; Liu J; Pins M; Doglio L; Dhir R; Gingrich J; Wang Z
Oncogene; 2008 Mar; 27(11):1536-44. PubMed ID: 17873910
[TBL] [Abstract][Full Text] [Related]
6. EAF2 loss induces prostatic intraepithelial neoplasia from luminal epithelial cells in mice.
Pascal LE; Rigatti LH; Ai J; Zhang A; Zhou J; Nelson JB; Wang Z
Am J Clin Exp Urol; 2020; 8(1):18-27. PubMed ID: 32211450
[TBL] [Abstract][Full Text] [Related]
7. Concurrent EAF2 and ELL2 loss phenocopies individual EAF2 or ELL2 loss in prostate cancer cells and murine prostate.
Zhong M; Pascal LE; Cheng E; Masoodi KZ; Chen W; Green A; Cross BW; Parrinello E; Rigatti LH; Wang Z
Am J Clin Exp Urol; 2018; 6(6):234-244. PubMed ID: 30697579
[TBL] [Abstract][Full Text] [Related]
8. Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.
Wang Y; Pascal LE; Zhong M; Ai J; Wang D; Jing Y; Pilch J; Song Q; Rigatti LH; Graham LE; Nelson JB; Parwani AV; Wang Z
Endocrinology; 2017 Dec; 158(12):4189-4205. PubMed ID: 29029019
[TBL] [Abstract][Full Text] [Related]
9. Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.
Elo TD; Valve EM; Seppänen JA; Vuorikoski HJ; Mäkelä SI; Poutanen M; Kujala PM; Härkönen PL
Neoplasia; 2010 Nov; 12(11):915-27. PubMed ID: 21076617
[TBL] [Abstract][Full Text] [Related]
10. Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.
Pascal LE; Masoodi KZ; Liu J; Qiu X; Song Q; Wang Y; Zang Y; Yang T; Wang Y; Rigatti LH; Chandran U; Colli LM; Vencio RZN; Lu Y; Zhang J; Wang Z
J Endocrinol; 2017 Nov; 235(2):123-136. PubMed ID: 28870994
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia.
Song Z; Wu X; Powell WC; Cardiff RD; Cohen MB; Tin RT; Matusik RJ; Miller GJ; Roy-Burman P
Cancer Res; 2002 Sep; 62(17):5096-105. PubMed ID: 12208767
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.
Su F; Pascal LE; Xiao W; Wang Z
Oncogene; 2010 Jan; 29(3):421-31. PubMed ID: 19826414
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice.
Kladney RD; Cardiff RD; Kwiatkowski DJ; Chiang GG; Weber JD; Arbeit JM; Lu ZH
Cancer Res; 2010 Nov; 70(21):8937-47. PubMed ID: 20940396
[TBL] [Abstract][Full Text] [Related]
14. Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN.
Sharma P; Knowell AE; Chinaranagari S; Komaragiri S; Nagappan P; Patel D; Havrda MC; Chaudhary J
Mol Cancer; 2013 Jun; 12():67. PubMed ID: 23786676
[TBL] [Abstract][Full Text] [Related]
15. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
[TBL] [Abstract][Full Text] [Related]
16. EAF2 mediates germinal centre B-cell apoptosis to suppress excessive immune responses and prevent autoimmunity.
Li Y; Takahashi Y; Fujii S; Zhou Y; Hong R; Suzuki A; Tsubata T; Hase K; Wang JY
Nat Commun; 2016 Mar; 7():10836. PubMed ID: 26935903
[TBL] [Abstract][Full Text] [Related]
17. Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.
Kelavkar UP; Parwani AV; Shappell SB; Martin WD
Neoplasia; 2006 Jun; 8(6):510-22. PubMed ID: 16820097
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
Oncotarget; 2016 May; 7(20):29245-54. PubMed ID: 27058417
[TBL] [Abstract][Full Text] [Related]
19. U19/Eaf2 binds to and stabilizes von hippel-lindau protein.
Xiao W; Ai J; Habermacher G; Volpert O; Yang X; Zhang AY; Hahn J; Cai X; Wang Z
Cancer Res; 2009 Mar; 69(6):2599-606. PubMed ID: 19258512
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of ELL-associated factor 2 in human prostate cancer.
Zang Y; Dong Y; Yang D; Xue B; Li F; Gu P; Zhao H; Wang S; Zhou S; Ying R; Wang Z; Shan Y
Int Urol Nephrol; 2016 May; 48(5):695-700. PubMed ID: 26895851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
